Lenvatinib Mesylate Yepakati CAS 205448-65-3 Kuchena > 98.0% (HPLC) Factory
Ruifu Chemical Supply Lenvatinib Mesylate Inopindirana Nekuchena Kwakanyanya
Lenvatinib Mesylate CAS 857890-39-2
4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
Desquinolinyl Lenvatinib;1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
4-Amino-3-Chlorophenol CAS 17609-80-2
4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Chemical Name | Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate |
Mashoko anoreva zvakafanana | 1,4-Dihydro-7-Methoxy-4-Oxo-6-Quinolinecarboxylic Acid Methyl Ester;7-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-6-Carboxylic Acid Methyl Ester;Lenvatinib Yepakati 3 |
Nhamba yeCAS | 205448-65-3 |
Nhamba yeCAT | RF-PI1973 |
Stock Status | MuStock, Kukwanisa Kugadzira 50 MT/Gore |
Molecular Formula | C12H11NO4 |
Molecular Weight | 233.22 |
Boiling Point | 421.0±45.0℃ |
Density | 1.267±0.060 g/cm3 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Off-White kusvika Yellowish Powder |
Kuchena / Analysis Method | >98.0% (HPLC) |
Kurasika paKuomesa | <1.00% |
Residue paIgnition | <0.50% |
Zvose Zvisina Kuchena | <2.00% |
H-NMR | Inopindirana neChimiro |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate (CAS: 205448-65-3) iri pakati peLenvatinib Mesylate (CAS: 857890-39-2).Lenvatinib, inotengeswa pasi pezita rezita rekuti Lenvima pakati pevamwe, mushonga unorwisa gomarara wekurapa mamwe marudzi egomarara rethyroid uye kune mamwe magomarara zvakare.Yakagadzirwa neEisai Co. uye inoshanda seyakawanda kinase inhibitor inopesana neVEGFR1, VEGFR2 uye VEGFR3 kinases.Lenvatinib inobvumirwa (kubvira 2015) yekurapa kwekenza yekenza yakasiyana-siyana iyo inogona kuitika munharaunda kana metastatic, inofambira mberi, uye haina kupindura kurapwa neradioactive iodine (radioiodine).Muna Chivabvu 2016, US Food and Drug Administration (FDA) yakazvibvumira (pamwe chete neeverolimus) kurapwa kwepamusoro renal cell carcinoma ichitevera imwe yekutanga anti-angiogenic therapy.Mushonga uyu unobvumidzwawo muUS uye muEuropean Union yehepatocellular carcinoma isingabviswe nekuvhiyiwa muvarwere vasina kuwana kurapwa kwegomarara nemuromo kana jekiseni.